Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Vertex Pharmaceuticals Inc DRC (VRTX34)

B3
Currency in BRL
690.81
0.00(0.00%)
Delayed Data

VRTX34 Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa4,162.86,205.77,574.48,930.79,869.2
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+36.59%+49.08%+22.06%+17.91%+10.51%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa2,302.32,381.22,8423,607.64,425.1
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa1,860.53,824.54,732.45,323.15,444.1
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+52.3%+105.56%+23.74%+12.48%+2.27%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa44.69%61.63%62.48%59.6%55.16%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa658.5770.5840.1944.71,136.6
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+18.09%+17.01%+9.03%+12.45%+20.31%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa658.5770.5840.1944.71,136.6
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,2023,0543,892.34,378.44,307.5
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+81.03%+154.08%+27.45%+12.49%-1.62%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa28.87%49.21%51.39%49.03%43.65%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa5.2-36-56.689.8570.6
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+115.24%-792.31%-57.22%+258.66%+535.41%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-58.5-58.2-61.5-54.8-44.1
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa63.722.24.9144.6614.7
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-5.4-15.3-12.2-15.7-15.3
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,201.83,002.73,823.54,452.54,862.8
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-4.5-197.7-1,110.2-71-475.5
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,394.93,116.92,730.44,232.44,379.8
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+132.39%+123.45%-12.4%+55.01%+3.48%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa33.51%50.23%36.05%47.39%44.38%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa218.1405.2388.3910.4760.2
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa1,176.82,711.72,342.13,3223,619.6
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa1,176.82,711.72,342.13,3223,619.6
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-43.88%+130.43%-13.63%+41.84%+8.96%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa28.27%43.7%30.92%37.2%36.68%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa1,176.82,711.72,342.13,3223,619.6
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa4.5810.449.0912.9714.05
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-44.39%+127.68%-12.93%+42.72%+8.28%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa4.5110.299.0112.8213.89
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-44.24%+128.16%-12.44%+42.29%+8.35%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa256.7259.8257.7256.1257.7
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa260.7263.4259.9259.1260.5
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa1,308.93,163.54,017.94,526.74,477
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+77.75%+141.69%+27.01%+12.66%-1.1%